重庆山外山血液净化技术股份有限公司2024年员工持股计划股份回购注销实施公告

Core Points - The company has decided to repurchase and cancel 1,715,024 shares from its 2024 employee stock ownership plan due to unmet performance targets [1][3][5] Group 1: Repurchase and Cancellation Details - The decision for the repurchase and cancellation was approved during the board meeting on August 19, 2025, and subsequently at the second extraordinary general meeting of shareholders on September 4, 2025 [2][4] - The repurchase is set to be completed by November 17, 2025, with the company applying for the transfer of shares to a dedicated repurchase account [4] Group 2: Financial Performance - For the fiscal year 2024, the company reported an audited revenue of 567 million and a net profit attributable to shareholders of 57 million, which was adjusted to 69 million after excluding non-recurring losses [3] Group 3: Impact on Shareholding Structure - Following the cancellation, the total share capital will decrease from 321,315,646 shares to 319,600,622 shares, resulting in a slight increase in the shareholding percentage of major shareholders from 8.97% to 9.01% [4][5] Group 4: Company Outlook - The repurchase and cancellation of shares are not expected to materially affect the company's financial status, operational results, or shareholder equity [5]